In the current study, WT1 expression was lower than what has been reported in most papers in the recent literature, which might be explained by the irregular staining of tissue for WT1, additionally, the TMAs used may not contain the most immunoreactivity areas of the tumours [9, 32, 33]. This evidence concerns the gene WT1 and neoplasm.